Home › Compare › SBHGF vs ABBV
SBHGF yields 6.53% · ABBV yields 3.06%● Live data
📍 SBHGF pulled ahead of the other in Year 1
Combined, SBHGF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SBHGF + ABBV for your $10,000?
SBI Holdings, Inc. engages in the online financial service businesses and investment activities in Japan and internationally. It operates through Financial Services Business; Asset Management Business; Investment Business, Crypto-Asset Business and Non-financial Business segments. The company offers financial products and services, including brokerage and investment banking; Internet banking; auto, cancer, fire, and earthquake, as well as life insurance; short term insurance; FX margin trading; online securities; exchange and transaction services related to digital assets; management of defined-contribution pension, etc.; leasing and lending services; operation of proprietary trading system; control and operation of the e-commerce settlement business; and remittance and back office support services. It also provides private equity, venture capital fund management, M&A advisory, commercial banking, investment advisory and management, and rating information services; real estate secured loans; and rent guarantees for rental housing. In addition, the company researches, manufactures, and sells pharmaceutical products, health foods, and cosmetics; develops, produces, sells, and maintains medical information integration systems; and researches and develops antibody drugs and nucleic acid medicines for cancer and immunology. Further, it operates a fund-raising platform; acts as a crypto-asset broker; develops, manufactures, and sells crypto-asset mining systems; operates and develops cybersecurity systems; provides blockchain platform; invests in real estate properties; exports used cars; and offers healthcare services, as well as revitalization services. Additionally, the company engages in the mining of digital assets; and e-sports and renewable energy business. The company was formerly known as Softbank Investment Corporation and changed its name to SBI Holdings, Inc. in July 2005. SBI Holdings, Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan.
Full SBHGF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.